Stock Ideas
New
Stocks
Funds
Screener
Sectors
Watchlists

Latest Novo Holdings A/S Stock Portfolio

$1.45Billion

Performance:
2024 Q1: -8.79%
3 Year: 9.42%

Performance for 2024 Q1 is -8.79% and the 3-year performance is 9.42%

About Novo Holdings A/S and it’s 13F Hedge Fund Stock Holdings

In it's latest 13F Holdings report, Novo Holdings A/S reported an equity portfolio of $1.4 Billions as of 31 Mar, 2024.

The top stock holdings of Novo Holdings A/S are ASML, , CRM. The fund has invested 12.2% of it's portfolio in ASML HOLDING N V and 11.2% of portfolio in BROOKFIELD CORP.

The fund managers got completely rid off TAIWAN SEMICONDUCTOR MFG LTD (TSM), EDGEWISE THERAPEUTICS INC (EWTX) and CYMABAY THERAPEUTICS INC (CBAY) stocks. They significantly reduced their stock positions in PHARVARIS N V (PHVS), APPLE INC (AAPL) and IO BIOTECH INC (IOBT). Novo Holdings A/S opened new stock positions in EDGEWISE THERAPEUTICS INC (EPC), VIRIDIAN THERAPEUTICS INC (VRDN) and ARRIVENT BIOPHARMA INC. The fund showed a lot of confidence in some stocks as they added substantially to LEXEO THERAPEUTICS INC.
Equity Portfolio Value
Last Reported on: 15 May, 2024

Performance Estimate

Our best estimate is that Novo Holdings A/S made a return of -8.79% in the last quarter. In trailing 12 months, it's portfolio return was 9.31%.

New Buys

Ticker$ Bought
edgewise therapeutics inc115,722,000
viridian therapeutics inc19,261,000
arrivent biopharma inc19,237,700
metagenomi inc18,348,300
kyverna therapeutics inc17,388,000

New stocks bought by Novo Holdings A/S

Additions

Ticker% Inc.
lexeo therapeutics inc25.27

Additions to existing portfolio by Novo Holdings A/S

Reductions

Ticker% Reduced
pharvaris n v-24.12
apple inc-17.38
io biotech inc-11.46
salesforce inc-9.49
asml holding n v-7.7
4d molecular therapeutics in-6.67
blueprint medicines corp-0.14
crinetics pharmaceuticals in-0.13

Novo Holdings A/S reduced stake in above stock

Sold off

Ticker$ Sold
spruce biosciences inc-19,696,400
edgewise therapeutics inc-66,424,400
lava therapeutics nv-2,967,550
rallybio corp-4,225,190
cymabay therapeutics inc-21,258,000
taiwan semiconductor mfg ltd-73,921,100

Novo Holdings A/S got rid off the above stocks

Sector Distribution

Novo Holdings A/S has about 40.5% of it's holdings in Others sector.

Sector%
Others40.5
Healthcare35.8
Technology12.3
Consumer Defensive8
Communication Services3.5

Market Cap. Distribution

Novo Holdings A/S has about 16% of it's portfolio invested in the large-cap and mega-cap stocks.

Category%
UNALLOCATED40.5
MID-CAP23.2
SMALL-CAP19.4
MEGA-CAP12.1
LARGE-CAP3.9

Stocks belong to which Index?

About 50% of the stocks held by Novo Holdings A/S either belong to S&P 500 or RUSSELL 2000 index.

Index%
Others50
RUSSELL 200037.9
S&P 50012.1
Top 5 Winners%
FDMT
4d molecular therapeutics in
55.7 %
CRNX
crinetics pharmaceuticals in
31.5 %
CRM
salesforce inc
14.1 %
PCVX
vaxcyte inc
8.8 %
GLTO
galecto inc
8.3 %
Top 5 Winners$
CRM
salesforce inc
19.7 M
FDMT
4d molecular therapeutics in
16.9 M
CRNX
crinetics pharmaceuticals in
12.3 M
PCVX
vaxcyte inc
4.7 M
EPC
edgewise therapeutics inc
2.5 M
Top 5 Losers%
SPRO
spero therapeutics inc
-99.3 %
CABO
cable one inc
-24.0 %
CORT
corcept therapeutics inc
-22.4 %
ALNY
alnylam pharmaceuticals inc
-21.9 %
ABCL
abcellera biologics inc
-20.7 %
Top 5 Losers$
SPRO
spero therapeutics inc
-122.6 M
CORT
corcept therapeutics inc
-17.6 M
CABO
cable one inc
-15.8 M
MIRM
mirum pharmaceuticals inc
-6.6 M
FOLD
amicus therapeutics inc
-6.0 M

Current Stock Holdings of Novo Holdings A/S

Novo Holdings A/S has 35 stocks in it's portfolio. About 63% of the portfolio is in top 10 stocks. SPRO proved to be the most loss making stock for the portfolio. CRM was the most profitable stock for Novo Holdings A/S last quarter.

Last Reported on: 15 May, 2024
TickerNamesorted ascending% PortfolioShares Held$ ValueType% ChangeOptions
AAPLapple inc2.16182,96031,374,000reduced-17.38
ABCLabcellera biologics inc0.351,126,9205,104,920unchanged0.00
ALNYalnylam pharmaceuticals inc1.22118,38317,692,300unchanged0.00
ASMLasml holding n v12.22182,536177,146,000reduced-7.7
BABAalibaba group hldg ltd2.50500,82736,239,800unchanged0.00
BAMbrookfield asset managmt ltd1.82627,20726,355,200unchanged0.00
BMRNbiomarin pharmaceutical inc2.71450,00039,303,000unchanged0.00
BPMCblueprint medicines corp2.35358,62634,019,300reduced-0.14
CABOcable one inc3.46118,40350,099,900unchanged0.00
CBAYcymabay therapeutics inc0.000.000.00sold off-100
CORTcorcept therapeutics inc4.192,411,36060,742,200unchanged0.00
CRMsalesforce inc9.98480,160144,615,000reduced-9.49
CRNXcrinetics pharmaceuticals in3.551,098,60051,425,500reduced-0.13
EPCedgewise therapeutics inc7.986,344,430115,722,000new
EWTXedgewise therapeutics inc0.000.000.00sold off-100
FDMT4d molecular therapeutics in3.081,400,00044,604,000reduced-6.67
FOLDamicus therapeutics inc2.032,500,00029,450,000unchanged0.00
GLTOgalecto inc0.132,497,7901,948,280unchanged0.00
INSMinsmed inc2.511,339,30036,335,300unchanged0.00
INSPinspire med sys inc0.9765,52414,073,900unchanged0.00
IOBTio biotech inc0.615,088,2608,802,690reduced-11.46
LVTXlava therapeutics nv0.000.000.00sold off-100
MIRMmirum pharmaceuticals inc2.601,500,00037,680,000unchanged0.00
MQmarqeta inc0.18441,5582,631,690unchanged0.00
PCVXvaxcyte inc3.98845,00057,722,000unchanged0.00
PHVSpharvaris n v1.861,168,03026,993,200reduced-24.12
RCKTrocket pharmaceuticals inc1.951,050,00028,287,000unchanged0.00
RLYBrallybio corp0.000.000.00sold off-100
SPRBspruce biosciences inc0.000.000.00sold off-100
SPROspero therapeutics inc0.06468,902806,511unchanged0.00
TMCItreace med concepts inc0.32360,0004,698,000unchanged0.00
TSMtaiwan semiconductor mfg ltd0.000.000.00sold off-100
VERVverve therapeutics inc1.832,000,00026,560,000unchanged0.00
VRDNviridian therapeutics inc1.331,100,00019,261,000new
brookfield corp11.213,880,230162,465,000unchanged0.00
lanzatech global inc3.3815,814,80048,946,900unchanged0.00
cargo therapeutics inc1.931,250,00027,900,000unchanged0.00
lexeo therapeutics inc1.771,638,30025,688,500added25.27
arrivent biopharma inc1.331,077,14019,237,700new
metagenomi inc1.271,739,18018,348,300new
kyverna therapeutics inc1.20700,00017,388,000new